6 articles
A meta-analysis of 8 studies finds intermittent fasting significantly reduces liver fat and improves key metabolic markers in MASLD patients.
With 225+ clinical trials behind it, intermittent fasting rivals calorie restriction for type 2 diabetes — yet major guidelines still ignore it.
A systematic review of RCTs finds night fasting windows improve glucose and lipid markers in shift workers, though evidence remains thin.
A new narrative review finds IF activates powerful antioxidant pathways, but warns that clinical proof in humans remains thin and short-term.
A meta-analysis of 4,941 adults finds FTO risk-allele carriers have higher triglycerides on calorie-restricted diets, but most metabolic markers respond similarly across genotypes.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.
